•Regulatory environment
•Technologies & platforms
•Scaling oligo therapeutics
•Reaching the patient
Moderator: ANDERS GABRIELSEN, Vice President & Head of Global Clinical Development, Ribocure Pharmaceuticals AB
Panellist:
ANNA PERDRIX, Chief Executive Officer, Sixfold Bioscience
SRITAMA BOSE, Associate Director of Chemistry, Orfonyx Bio
VIVEK VERMA, Lecturer, University College of Cork
